We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Perimenopause × Peptides
Perimenopause is where the damage starts — and where intervention pays the biggest dividend. Most women lose 3–7 "tissue years" before their final period.
If your skin is changing, sleep is fragmenting, joints are stiffening, and recovery is slowing — you are mid-transition. The Tissue Clock quantifies it.
Recommended starting point for this profile: Comprehensive Longevity Protocol. Book Telehealth Consult →
The Kindr Tissue Clock™
70% of doctors are untrained in estrogen decline, and 33% of women skip insurance entirely to find specialized care (PwC, 2024). Don't wait for a diagnosis. Take the 60-second E.C.R. (Estrogen-Collagen-Regeneration) assessment to find your biological tissue age and your 30-year downstream risk profile for bone, heart, and brain.
60 seconds · No login · Free
ECR Matrix & Protocol data last verified: · Medically reviewed by Kindr Health Clinical Team
BPC-157 for systemic repair, GHK-Cu for skin/collagen, and growth-axis support like Sermorelin or CJC-1295/Ipamorelin for recovery and body composition.
For most women in perimenopause the highest-ROI stack is foundational HRT + targeted peptides. HRT restores the substrate; peptides accelerate the repair.
Related evidence, peptides, and clinical tools on the same topic.